Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,265-18,276 of 23,847
Drug study icon
CompletedNCT00230828

Patient-reported Outcomes in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
Sponsor
Solvay Pharmaceuticals
Condition
Schizophrenia
Behavioral study icon
WithdrawnNCT03244852

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In Charlestown
OCDOtherFrom 21 Years to 64 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
OCD
Other study type icon
UnknownNCT06616337

Patients Suffering From Emotional Dysregulation

This observational study is following people with Emotional Dysregulation to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Strasbourg
BipolarityOtherOver 18 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Bipolarity
Device study icon
UnknownNCT06350396

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

This study is looking at whether active rTMS treatment can help people with Treatment Resistant Depression or depression. Participants take part in active rTMS treatment and complete follow-up assessments.

Multiple locations, including Hebei
DepressionDeviceFrom 18 Years to 65 Years
Countries
China
Sponsor
Changping Laboratory
Condition
Depression
Drug study icon
CompletedNCT06391593

PD, PK, and Safety of ALTO-203 in people with MDD

This study exists to learn from real-world information that can show how the medication ALTO-203 fits into care. Researchers are trying to understand whether the medication ALTO-203 can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Tucson
DepressionDrugFrom 25 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.